Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER

Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER

Abstract Background A number of single-inhaler triple therapies are being developed for asthma, including the extrafine formulation of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium (G). Given asthma is a heterogenous disease, we investigated whether the clinical resp...

Full description

Bibliographic Details
Main Authors: Dave Singh, Johann Christian Virchow, Giorgio Walter Canonica, Andrea Vele, Maxim Kots, George Georges, Alberto Papi
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Respiratory Research
Subjects:
Asthma
Pharmacotherapy
Long-acting β2-agonists
Long-acting muscarinic antagonists
Inhaled corticosteroids
Subgroup analyses
Online Access:http://link.springer.com/article/10.1186/s12931-020-01558-y

Internet

http://link.springer.com/article/10.1186/s12931-020-01558-y

Similar Items